Solara Active Pharma Sciences Ltd (SOLARA) — Announcement | 28 August 2026

· BSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company receives rectification order cancelling Rs. 161.92 Crore tax demand
🔄 What Changed
Tax demand reduced to Nil
💡 Investor Takeaway
The tax liability has been fully cleared, eliminating a previously disclosed contingent liability.

Solara Active Pharma Sciences received a rectification order from the Assistant Commissioner of Income Tax, Central Circle 3, Thane, dated August 8, 2026, that cancels a previously issued tax demand of Rs. 161.92 Crores from March 17, 2026. The order resolves the incorrect tax computation and eliminates all pending demands, leaving the company's financial position unchanged. This correction removes a liability that was under review but had no operational or financial impact on the business.

📄 View Original Announcement (PDF)

About Solara Active Pharma Sciences Ltd (SOLARA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹3,425.95 Cr ROE: -0.1% ROCE: 4.7%

View full SOLARA stock details →

📡 Get AI alerts when SOLARA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SOLARA — Free

📊 More SOLARA filings

See all SOLARA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SOLARA files new disclosures

Track SOLARA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SOLARA — Free

Free account · 2 AI queries/day